Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI | TechCrunch
Briefly

from TechCrunch2 months ago
Aqemia, a French startup, states it uses quantum-inspired physics and machine learning to generate synthetic data for predicting drug properties, streamlining the drug discovery process.
TechCrunchhttps://techcrunch.com/2024/12/10/aqemia-raises-38m-to-find-new-drugs-by-meshing-theoretical-physics-with-genai/
With a total funding of over $100 million, Aqemia is positioned at the forefront of AI-driven drug discovery, targeting critical diseases like cancer and immuno-oncology.
TechCrunchhttps://techcrunch.com/2024/12/10/aqemia-raises-38m-to-find-new-drugs-by-meshing-theoretical-physics-with-genai/
The integration of AI into drug discovery is gaining momentum, as evidenced by significant funding rounds not only for Aqemia, but for various players in the industry.
TechCrunchhttps://techcrunch.com/2024/12/10/aqemia-raises-38m-to-find-new-drugs-by-meshing-theoretical-physics-with-genai/
Aqemia's partnership with Sanofi shows their potential, as the multi-year agreement could reach values up to $140 million based on R&D results.
TechCrunchhttps://techcrunch.com/2024/12/10/aqemia-raises-38m-to-find-new-drugs-by-meshing-theoretical-physics-with-genai/
Read at TechCrunch
#drug-discovery #machine-learning #funding #quantum-physics #ai
[
|
]